Failure to Track and Investigate Resident HSV Infection
Summary
The facility failed to implement and operationalize a comprehensive infection prevention and control program, including outcome and process surveillance, accurate data collection, documentation, analysis, and tracking for one resident with an infection-related event. The resident had an admission diagnosis of vascular dementia with agitation, depressive disorder, and chronic obstructive pulmonary disease, and a BIMS score of 00 indicating severe cognitive impairment. The resident’s care plan directed staff to observe skin during showers and care and to notify the nurse immediately of any new skin breakdown, redness, blisters, bruises, or discoloration. Progress notes documented that the resident was found with white bumps on the vaginal labia, with multiple whitish raised bumps and swollen labia, and no complaints of pain or itching. A physician ordered acyclovir the same day, and a nurse manager later entered laboratory orders for STD testing, including HSV-1, HSV-2, HIV antibody, syphilis antibody, chlamydia, and gonorrhea. The laboratory results later showed positive HSV type 1 and type 2. During interviews, the DON and nurse manager stated they did not remember the incident, and the nurse manager said she did not think anything of the STD labs, did not question why they were ordered, and did not discuss the vaginal blisters, acyclovir, or STD labs with the DON or abuse coordinator. The infection preventionist stated she received the resident being started on acyclovir on her dashboard, but said the physician ordered the antiviral and that was it, and that the resident did not need to be monitored. The NHA, who was also the abuse coordinator, stated the lab results proved the resident had herpes antibodies and there was no need to report or investigate. The DON later stated the unexplained positive HSV type 1 and type 2 should have been reported and investigated, and that the care plan and diagnosis list should have been updated. The facility’s infection prevention policy stated resident infection cases are monitored by the infection preventionist, who completes the infection surveillance tracking tool, reports to the infection prevention committee, provides feedback to staff, reports notifiable diseases to the local health department as directed, and monitors and documents compliance through surveillance and observation.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.